Incyte's stock valuation is on the higher side given looming patent expiries for Jakafi and Opzelura, and uncertain pipeline ...

In the latest instalment of a long-running dispute, the Court of Appeal has recently upheld the High Court judge's view on whether the Defendants had breached the terms of an order made in July 2020, ...

Merck (NYSE:MRK) operates within the healthcare sector, which plays a significant role in S&P 500 Index Fund index.

Merck KGaA (Merck) is filing for global regulatory approvals of its CSF-1R inhibitor pimicotinib after it met the primary and ...

Germany’s Merck KGaA (MRK: DE) today announced the presentation of detailed positive results from Part 1 of the global Phase ...

The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used ...

SpringWorks Therapeutics SWTX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending conditional ...

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...